The in vivo effect of bilirubin on the N-methyl-D-aspartate receptor/ion channel complex in the brains of newborn piglets

Pediatric Research

Volumn 40, Issue 6, 1996, Pages 804-808

  Hoffman, David J ^a,c   Zanelli, Santina A ^b   Kubin, Joanna ^b   Mishra, Om Prakash ^b   Delivoria Papadopoulos, Maria ^b  

^a ST CHRISTOPHER'S HOSPITAL FOR CHILDREN   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BILIRUBIN; DIZOCILPINE; GLUTAMIC ACID; ION CHANNEL; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; SULFAFURAZOLE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN INJURY; BRAIN MATURATION; CELL MEMBRANE PERMEABILITY; CONTROLLED STUDY; HYPERBILIRUBINEMIA; KERNICTERUS; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; SWINE;

EID: 0029828966     PISSN: 00313998     EISSN: None     Source Type: Journal    
DOI: 10.1203/00006450-199612000-00005     Document Type: Article

References (41)

1. Hansen TWR, Bratlid D 1986 Bilirubin and brain toxicity. Acta Paediatr Scand 75:513-522
2. Perlstein MA 1960 The late clinical syndrome of posticteric encephalopathy. Pediatr Clin North Am 7:665-687
3. Ahdab-Barmada M, Moossy J 1982 The neuropathology of kernicterus in the premature infant: diagnostic problems. J Neuropathol Exp Neurol 43:45-56
4. Maisels MJ 1994 Bilirubin. In: A very GB, Fletcher MA, MacDonald MG (eds) Neonatology: Pathophysiology and Management of the Newborn, 4th Ed. JB Lippincott, Philadelphia, pp 630-725
5. Stone TW 1993 Subtypes of nmda receptors. Gen Pharmacol 24:825-832
6. McDonald JW, Johnston MV 1990 Physiological and pathophysiological roles of excitatory amino acids during central nervous system development. Brain Res Rev 15:41-70
7. Monaghan D, Bridges R, Cotman C, 1989 The excitatory amino acid receptors: their classes, pharmacology, and distinct properties in the function of the central nervous system. Annu Rev Pharmacol Toxicol 29:365-402
8. Scatton, B 1993 The NMDA receptor complex. Fundam Clin Pharmacol 7:389-400
9. Chazot PL, Coleman SK, Cik M, Stephenson FA 1994 Molecular characterization of N-methyl-D-aspartate receptors expressed in mammalian cells yields evidence for the coexistence of three subunit types within a discrete receptor molecule. J Biol Chem 269:24403-24409
10. Seeburg PH 1993 The Tips/TINS lecture: the molecular biology of mammalian glutamate receptor channels. Trends Pharmacol Sci 14:297-303
11. Moriyoshi K, Masayuki M, Ishii T, Shigemoto R, Mizuno N, Nakanishi S 1991 Molecular cloning and characterization of the rat NMDA receptor. Nature 354:31-37
12. Reynolds I 1990 Modulation of NMDA receptor responsiveness by neurotransmitters, drugs and chemical modification. Life Sci 47:1785-1792
13. Collingridge GL, Lester RA 1989 Excitatory amino acid receptors in the vertebrate central nervous system. Pharmacol Rev 40:145-210
14. Johnston M, McDonald M, Chen C, Trescher W 1991 Role of excitatory amino acid receptors in perinatal hypoxic-ischemic brain injury. In: Meldrum BS, Moroni F, Simon RP, Woods JH (eds) Excitatory Amino Acids. Raven Press, New York, pp 711-716
15. Hoffman DJ, McGowan JE, Marro P, Mishra, OP, Delivoria-Papadopoulos, M 1994 Hypoxia-induced modification of the N-methyl-D-aspartate (NMDA) receptor in the brain of newborn piglets. Neurosci Lett 167:156-160
16. Hansen TWR, Paulsen O, Gjerstad L, Bratlid D 1988 Short-term exposure to bilirubin reduces synaptic activation in rat transverse hippocampal slices. Pediatr Res 23:453-456
17. Brodersen R 1979 Bilirubin solubility and interaction with albumin and phospholipid. J Biol Chem 254:2364-2369
18. Brann IV BS, Stonestreet BS, Oh W, Cashore, W 1987 The in vivo effect of bilirubin and sulfisoxazole on cerebral oxygen, glucose, and lactate metabolism in newborn piglets. Pediatr Res 22:135-141
19. Hansen TWR, Cashore WJ, Oh W 1992 Changes in piglet auditory brainstem response amplitudes without increases in serum or cerebrospinal fluid neuron-specific enolase. Pediatr Res 32:524-529
20. Cashore WJ, Oh W, Brodersen R 1983 Bilirubin-displacing effect of furosemide and sulfisoxazole. Dev Pharmacol Ther 6:230-238
21. 3[H]MK-801 to the N-methyl-D-aspartate: pharmacological evidence for the existence of a polyamine recognition site. Mol Pharmacol 36:575-581
22. Lowry O, Rosenbrough NJ, Farr AL, Randall RJ 1951 Protein measurement with the Folin phenol reagent. J Biol Chem 193:265-275
23. Fiske CH, Subbarow Y 1925 The colorimetric determination of phosphorus. J Biol Chem 66:375-400
24. Lamprecht W, Stein P, Heinz F, Weissner H 1974 Creatine phosphate. In: Bergmeyer HU (ed) Methods of Enzymatic Analysis, Vol. 4. Academic Press, New York, pp 1777-1781
25. Shapiro SM 1993 Reversible brainstem auditory evoked potential abnormalities in jaundiced Gunn rats given sulfanamide. Pediatr Res 34:629-633
26. 31P nuclear magnetic resonance spectroscopy. Pediatr Res 26:356-361
27. Amit Y, Cashore W, Schiff D 1992 Studies of bilirubin toxicity at the synaptosome and cellular levels. Semin Perinatol 16:186-190
28. Roger C, Koziel V, Vert P, Nehlig A 1993 Effects of bilirubin infusion on local cerebral glucose utilization in the immature rat. Dev Brain Res 76:115-130
29. Ochoa ELM, Wennberg R, An Y, Tandon T, Takashima T, Nguyen T, Chui A 1993 Interactions of bilirubin with isolated presynaptic nerve terminals: functional effects on the uptake and release of neurotransmitters. Cell Mol Biol 13:69-86
30. McDonald JW, Shapiro SM, Silverstein FS, Johnston MV 1990 Excitatory amino acid neurotransmitter systems contribute to the pathophysiology of bilirubin encephalopathy. Ann Neurol 28:413A
31. +-ATPase and acetylcholinesterase activities: changes in postnatally developing rat brain induced by bilirubin. Pharmacol Biochem Behav 45:363-368
32. Wennberg RP, Johansson BB, Folbergrova J, Siesjo BK 1991 Bilirubin-induced changes in brain energy metabolism after osmotic opening of the blood-brain barrier. Pediatr Res 30:473-478
33. Volpe JJ 1995 Bilirubin and brain injury. In: Volpe JJ (ed) Neurology of the Newborn. WB Saunders, Philadelphia, pp 490-514
34. Edelman AM, Blumenthal DK, Krebs EG 1987 Protein serine/threonine kinases. Annu Rev Biochem 56:567-613
35. Saitoh T, Masliah E, Jin LW, Cole GM, Wieloch T, Shapiro IP 1991 Biology of disease: protein kinases and phosphorylation in neurological disorders and cell death. Lab Invest 64:596-616
36. Amit Y, Boneh A 1993 Bilirubin inhibits protein kinase C activity and protein kinase C-mediated phosphorylation of endogenous substrates in human skin fibroblasts. Clin Chim Acta 223:103-111
37. Hansen TWR, Mathiesen SBW, Walaas SI 1996 Bilirubin has widespread effects on protein phosphorylation. Pediatr Res 39:1072-1077
38. Raymond LA, Tingley, Blackstone CD, Roche KW 1994 Glutamate receptor modulation by protein phosphorylation. J Physiol (Paris) 88:181-192
39. Raymond LA, Blackstone CD, Huganir RL 1994 Phosphorylation of amino acid neurotransmitter receptors in synaptic plasticity. Trends Neurosci 16:147-153
40. Bonhaus DW, McNamara JO 1988 N-Methyl-D-aspartate receptor regulation of uncompetitive antagonist binding in rat brain membranes: kinetic analysis. Mol Pharmacol 34:250-255
41. Bratlid D 1990 How bilirubin gets into the brain. Clin Perinatol 17:449-465